Ceftaroline Fosamil: A Review of its Use in the Treatment of Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ceftaroline Fosamil: A Review of its Use in the Treatment of Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia
Authors
Keywords
Ceftriaxone, Tigecycline, Aztreonam, Clinical Cure Rate, Ceftaroline
Journal
DRUGS
Volume 73, Issue 10, Pages 1067-1094
Publisher
Springer Nature
Online
2013-06-25
DOI
10.1007/s40265-013-0075-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of the Effect of a Supratherapeutic Dose of Intravenous Ceftaroline Fosamil on the Corrected QT Interval
- (2013) Todd A. Riccobene et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Assessment of ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia due to Streptococcus pneumoniae: insights from two randomized trials
- (2013) Andrew F. Shorr et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Antimicrobial activity of ceftaroline and comparator agents tested against bacterial isolates causing skin and soft tissue infections and community-acquired respiratory tract infections isolated from the Asia-Pacific region and South Africa (2010)
- (2013) Helio S. Sader et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Spectrum and potency of ceftaroline tested against leading pathogens causing skin and soft-tissue infections in Europe (2010)
- (2013) David J. Farrell et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- CANVAS 1 and 2: Analysis of Clinical Response at Day 3 in Two Phase 3 Trials of Ceftaroline Fosamil versus Vancomycin plus Aztreonam in Treatment of Acute Bacterial Skin and Skin Structure Infections
- (2012) H. David Friedland et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy of Human Simulated Exposures of Ceftaroline against Phenotypically Diverse Enterobacteriaceae Isolates
- (2012) Seth T. Housman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivity of Ceftaroline against Clinical Isolates of Streptococcus pneumoniae Recovered in 43 U.S. Medical Centers during 2010-2011
- (2012) Gary V. Doern et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of Ceftaroline-Avibactam Tested against Gram-Negative Organism Populations, including Strains Expressing One or More β-Lactamases and Methicillin-Resistant Staphylococcus aureus Carrying Various Staphylococcal Cassette ChromosomemecTypes
- (2012) Mariana Castanheira et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy of Ceftaroline Fosamil in a Staphylococcal Murine Pneumonia Model
- (2012) Amira A. Bhalodi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of Ceftaroline Activity versus Ceftriaxone against Clinical Isolates of Streptococcus pneumoniae with Various Susceptibilities to Cephalosporins in anIn VitroPharmacokinetic/Pharmacodynamic Model
- (2012) Molly E. Steed et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Summary of Ceftaroline Activity against Pathogens in the United States, 2010: Report from the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) Surveillance Program
- (2012) Robert K. Flamm et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- AWARE Ceftaroline Surveillance Program (2008–2010): Trends in Resistance Patterns Among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States
- (2012) Michael A. Pfaller et al. CLINICAL INFECTIOUS DISEASES
- Prevalence of Methicillin-Resistant Staphylococcus aureus as an Etiology of Community-Acquired Pneumonia
- (2012) G. J. Moran et al. CLINICAL INFECTIOUS DISEASES
- Ceftaroline Fosamil: A Cephalosporin With Activity Against Methicillin-Resistant Staphylococcus Aureus
- (2012) Henry Poon et al. CLINICAL THERAPEUTICS
- Spectrum and potency of ceftaroline tested against leading pathogens causing community-acquired respiratory tract infections in Europe (2010)
- (2012) David J. Farrell et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Ceftaroline Fosamil in the Treatment of Community-Acquired Bacterial Pneumonia and Acute Bacterial Skin and Skin Structure Infections
- (2012) Thomas P. Lodise et al. DRUGS
- Ceftaroline fosamil for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infection
- (2012) Anthony M Casapao et al. EXPERT OPINION ON PHARMACOTHERAPY
- Ceftaroline fosamil: a new cephalosporin active against resistant Gram-positive organisms including MRSA
- (2012) Mark W Garrison et al. Expert Review of Anti-Infective Therapy
- In vitro activity of ceftaroline and comparator antimicrobials against European and Middle East isolates from complicated skin and skin-structure infections collected in 2008–2009
- (2012) Ian Morrissey et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Assessment of the activity of ceftaroline against clinical isolates of penicillin-intermediate and penicillin-resistant Streptococcus pneumoniae with elevated MICs of ceftaroline using an in vitro pharmacodynamic model
- (2012) G. G. Zhanel et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of ceftaroline against serotyped Streptococcus pneumoniae isolates from Europe and South Africa associated with community-acquired bacterial pneumonia (2007–08)
- (2012) Ian Morrissey et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Characterization of methicillin-resistant Staphylococcus aureus displaying increased MICs of ceftaroline
- (2012) R. E. Mendes et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of Ceftaroline and Epidemiologic Trends in Staphylococcus aureus Isolates Collected from 43 Medical Centers in the United States in 2009
- (2011) Sandra S. Richter et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multistep Resistance Development Studies of Ceftaroline in Gram-Positive and -Negative Bacteria
- (2011) Catherine Clark et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ceftaroline versus Ceftriaxone in a Highly Penicillin-Resistant Pneumococcal Pneumonia Rabbit Model Using Simulated Human Dosing
- (2011) Delphine Croisier-Bertin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy of Human Simulated Exposures of Ceftaroline Administered at 600 Milligrams Every 12 Hours against Phenotypically Diverse Staphylococcus aureus Isolates
- (2011) Rebecca A. Keel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of Ceftaroline against Gram-Positive and Gram-Negative Pathogens Isolated from Patients in Canadian Hospitals in 2009
- (2011) James A. Karlowsky et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of Ceftaroline Activity versus Daptomycin (DAP) against DAP-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Strains in anIn VitroPharmacokinetic/Pharmacodynamic Model
- (2011) Molly Steed et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
- (2011) Catherine Liu et al. CLINICAL INFECTIOUS DISEASES
- Guidelines for the management of adult lower respiratory tract infections - Summary
- (2011) M. Woodhead et al. CLINICAL MICROBIOLOGY AND INFECTION
- Integrated safety summary of FOCUS 1 and FOCUS 2 trials: Phase III randomized, double-blind studies evaluating ceftaroline fosamil for the treatment of patients with community-acquired pneumonia
- (2011) D. R. Rank et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Ceftaroline fosamil: a new broad-spectrum cephalosporin
- (2011) J. B. Laudano JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Ceftaroline pharmacodynamic activity versus community-associated and healthcare-associated methicillin-resistant Staphylococcus aureus, heteroresistant vancomycin-intermediate S. aureus, vancomycin-intermediate S. aureus and vancomycin-resistant S. aureus using an in vitro model
- (2011) G. G. Zhanel et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia
- (2011) Donald E. Low et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia
- (2011) T. M. File et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Comparison of ceftaroline fosamil, daptomycin and tigecycline in an experimental rabbit endocarditis model caused by methicillin-susceptible, methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus
- (2011) C. Jacqueline et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Comparative ceftaroline activity tested against pathogens associated with community-acquired pneumonia: results from an international surveillance study
- (2011) R. N. Jones et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- General Principles of Antimicrobial Therapy
- (2011) Surbhi Leekha et al. MAYO CLINIC PROCEEDINGS
- Affinity of Ceftaroline and Other -Lactams for Penicillin-Binding Proteins from Staphylococcus aureus and Streptococcus pneumoniae
- (2010) K. Kosowska-Shick et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivity of Ceftaroline against a Broad Spectrum of Recent Clinical Anaerobic Isolates
- (2010) David R. Snydman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of Ceftaroline against 623 Diverse Strains of Anaerobic Bacteria
- (2010) D. M. Citron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effect of Ceftaroline on Normal Human Intestinal Microflora
- (2010) G. Panagiotidis et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of Ceftaroline against Community-Associated Methicillin-Resistant, Vancomycin-Intermediate, Vancomycin-Resistant, and Daptomycin-Nonsusceptible Staphylococcus aureus Isolates
- (2010) L. Saravolatz et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of Ceftaroline against Recent Emerging Serotypes of Streptococcus pneumoniae in the United States
- (2010) M. R. Jacobs et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Integrated Analysis of CANVAS 1 and 2: Phase 3, Multicenter, Randomized, Double‐Blind Studies to Evaluate the Safety and Efficacy of Ceftaroline versus Vancomycin plus Aztreonam in Complicated Skin and Skin‐Structure Infection
- (2010) G. Ralph Corey et al. CLINICAL INFECTIOUS DISEASES
- Integrated Analysis of FOCUS 1 and FOCUS 2: Randomized, Doubled‐Blinded, Multicenter Phase 3 Trials of the Efficacy and Safety of Ceftaroline Fosamil versus Ceftriaxone in Patients with Community‐Acquired Pneumonia
- (2010) Thomas M. File et al. CLINICAL INFECTIOUS DISEASES
- Not Community-Associated Methicillin-Resistant Staphylococcus aureus (CA-MRSA)! A Clinician's Guide to Community MRSA - Its Evolving Antimicrobial Resistance and Implications for Therapy
- (2010) K. Chua et al. CLINICAL INFECTIOUS DISEASES
- In vitro evaluation of ceftaroline alone and in combination with tobramycin against hospital-acquired meticillin-resistant Staphylococcus aureus (HA-MRSA) isolates
- (2010) Céline Vidaillac et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Evolving trends in Streptococcus pneumoniae resistance: implications for therapy of community-acquired bacterial pneumonia
- (2010) Ronald N. Jones et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- AmpC induction by ceftaroline
- (2010) S. Mushtaq et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections
- (2010) M. H. Wilcox et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efficacy of the new cephalosporin ceftaroline in the treatment of experimental methicillin-resistant Staphylococcus aureus acute osteomyelitis
- (2010) C. Jacqueline et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The problem of complicated skin and skin structure infections: the need for new agents
- (2010) R. C. Moellering JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections
- (2010) G. R. Corey et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Ceftaroline activity against pathogens associated with complicated skin and skin structure infections: results from an international surveillance study
- (2010) R. N. Jones et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Ceftaroline fosamil: a novel broad-spectrum cephalosporin with expanded anti-Gram-positive activity
- (2010) D. Biek et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Binding of ceftaroline to penicillin-binding proteins of Staphylococcus aureus and Streptococcus pneumoniae
- (2010) H. Moisan et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Integrated safety summary of CANVAS 1 and 2 trials: Phase III, randomized, double-blind studies evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections
- (2010) M. L. Corrado JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Community-associated meticillin-resistant Staphylococcus aureus
- (2010) Frank R DeLeo et al. LANCET
- Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Europe
- (2010) Jonathan A Otter et al. LANCET INFECTIOUS DISEASES
- Ceftaroline: A New Cephalosporin with Activity Against Resistant Gram-Positive Pathogens
- (2010) Molly E Steed et al. PHARMACOTHERAPY
- In Vitro Activity of Ceftaroline Alone and in Combination against Clinical Isolates of Resistant Gram-Negative Pathogens, Including -Lactamase-Producing Enterobacteriaceae and Pseudomonas aeruginosa
- (2009) C. Vidaillac et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vivo Activity of a Novel Anti-Methicillin-Resistant Staphylococcus aureus Cephalosporin, Ceftaroline, against Vancomycin-Susceptible and -Resistant Enterococcus faecalis Strains in a Rabbit Endocarditis Model: a Comparative Study with Linezolid and Vancomycin
- (2009) C. Jacqueline et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of Ceftaroline against Methicillin-Resistant Staphylococcus aureus and Heterogeneous Vancomycin-Intermediate S. aureus in a Hollow Fiber Model
- (2009) C. Vidaillac et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical impact of antibiotic-resistant Gram-positive pathogens
- (2009) H.M. Lode CLINICAL MICROBIOLOGY AND INFECTION
- New treatments for methicillin-resistant Staphylococcus aureus
- (2009) Martin E Stryjewski et al. Current Opinion in Critical Care
- Ceftaroline
- (2009) George G. Zhanel et al. DRUGS
- Ceftobiprole: a novel cephalosporin with activity against Gram-positive and Gram-negative pathogens, including methicillin-resistant Staphylococcus aureus (MRSA)
- (2009) April Barbour et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In vitro activity of ceftaroline, ceftobiprole and cethromycin against clinical isolates of Streptococcus pneumoniae collected from across Canada between 2003 and 2008
- (2009) S. N. Patel et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Limitations of antibiotic options for invasive infections caused by methicillin-resistant Staphylococcus aureus: is combination therapy the answer?
- (2009) H. M. Nguyen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- BTS guidelines for the management of community acquired pneumonia in adults: update 2009
- (2009) W S Lim et al. THORAX
- In Vitro Evaluation of the Antimicrobial Activity of Ceftaroline against Cephalosporin-Resistant Isolates of Streptococcus pneumoniae
- (2008) L. McGee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of Ceftaroline against Streptococcus pneumoniae Isolates Exhibiting Resistance to Penicillin, Amoxicillin, and Cefotaxime
- (2008) A. Fenoll et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Profiling of Ceftaroline against a Collection of Recent Bacterial Clinical Isolates from across the United States
- (2008) Y. Ge et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Broad‐Spectrum Antimicrobials and the Treatment of Serious Bacterial Infections: Getting It Right Up Front
- (2008) Marin H. Kollef CLINICAL INFECTIOUS DISEASES
- Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community
- (2008) Dilip Nathwani et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Co-opting the Cell Wall in Fighting Methicillin-ResistantStaphylococcus aureus: Potent Inhibition of PBP 2a by Two Anti-MRSA β-Lactam Antibiotics
- (2008) Adriel Villegas-Estrada et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started